Nova Vision logo

About NovaVision VRT™ Vision Restoration Therapy™

Based on groundbreaking research in neuroplasticity — the brain's ability to heal itself — NovaVision VRT Vision Restoration Therapy is a non-invasive way to provide vision rehabilitation to patients after a stroke or traumatic brain injury (TBI) has left them with visual deficits. VRT offers promising results beyond physical, occupational, and speech therapies — the traditional, mainstream treatments for survivors of stroke and TBI. VRT is the first clinical application of low vision therapy to be cleared by the FDA.

NovaVision™, Inc. — Dedicated to Restoring Lost Vision

Based on a decade of scientific research, NovaVision (sometimes misspelled as Nova Vision) offers stroke and TBI patients suffering from vision loss the opportunity for a diagnostic visual examination and treatment for their visual field deficits. Most vision therapy patients have displayed improvements in their vision, with more than 70 percent of patients who completed Vision Restoration Therapy showing improvements in their vision that enhance their quality of life.

Daily Life Improvements May Include

Vision Deficits Treated with Vision Restoration Therapy

Learn more about Vision Rehabilitation after Stroke or TBI

To learn more about NovaVision, the field of neuroplasticity, and VRT, please explore the links above, read our Frequently Asked Questions, call us at 1.866.663.0800, or request information over email.

News about NovaVision Vision Restoration Therapy

NovaVision™ Announces Launch of New Visual Assessment Device CentraVIEW™ at April’s AAN Meeting

The launch of NovaVision's newest product, CentraVIEW™ was announced at the American Academy of Neurology's (AAN) annual meeting in April. Product demonstrations were also performed on the new device for attendess throughout the conference.

Wall Street Journal Feature: NovaVision™ VRT™ Research & Improvements for Stroke Vision Loss Patient

The Wall Street Journal Health story, Reversing Partial Blindness reports on VRT™ as "A Revolution in Neuroscience," and describes how VRT can restore the vision of patients who have suffered partial blindness as a result of a stroke or traumatic brain injury (TBI).

Noticeable Improvements for Retired M.D. Patient: "I Recommend VRT™."

Retired physician and current VRT patient is pleased with noticeable vision improvements that have enhanced his quality of life. This 3-year, post-stroke vision loss patient encourages medical professionals and rehabilitation specialists to advise their stroke and traumatic brain injury patients about the benefits of NovaVision VRT™.

The Team behind NovaVision VRT Vision Restoration Therapy

Louis R. Caplan, M.D.

Professor of Neurology, Harvard Medical School Chief of the Division of Cerebrovascular Disease Department of Neurology, Beth Israel Deaconess Medical Center

Andrew Firlik, M.D.

Clinical Assistant Professor of Neurosurgery, New York University School of Medicine

Alvaro Pascual-Leone, M.D., Ph.D.

Director, Center for Non-Invasive Brain Stimulation and Professor of Neurology, Harvard Medical School and the Beth Israel Deaconess Medical Center

Misha Pless, M.D.

Director, Division General Neurology, Neuro-ophthalmology, Massachusetts General Hospital; Associate Professor of Neurology, Harvard Medical School

Vilayanur S. Ramachandran, M.D., Ph.D.

Director of the Center for Brain and Cognition, and Professor of Psychology and Neurosciences Program at University of California, San Diego

Jose G. Romano, M.D.

Associate Professor of Neurology, Cerebrovascular Division; Associate Chair for Clinical Affairs, Department of Neurology University of Miami Miller School of Medicine

Norman J. Schatz, M.D.

Professor of Neuro-Ophthalmology, University of Miami School of Medicine

Carla J. Shatz, Ph.D.

Director, BioX James H. Clark Center Stanford University

Torsten Wiesel, M.D.

Neuroscientist, Nobel Laureate President Emeritus, Rockefeller University